Cigna Group
CIAPI behind this page
CI Q4 2025 request
Playground key active
/api/financials?ticker=CI&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Home delivery and specialty revenues · Evernorth Health Services | 21,068 | 19,092 | +10.3% |
| Network revenues · Evernorth Health Services | 34,254 | 28,545 | +20.0% |
| Other revenues · Evernorth Health Services | 3,416 | 3,112 | +9.8% |
| Product | 58,336 | 49,941 | +16.8% |
| Product · All Other Segments | 13 | 13 | 0.0% |
| Product · Corporate and Eliminations | -415 | -821 | +49.5% |
| Product · Evernorth Health Services | 58,738 | 50,749 | +15.7% |
| Service | 4,509 | 3,928 | +14.8% |
| Service Other | 144 | 75 | +92.0% |
| Service, Fees And Other Revenues [Member] | 4,509 | 3,928 | +14.8% |
| Service, Fees And Other Revenues [Member] · All Other Segments | 3 | 15 | -80.0% |
| Service, Fees And Other Revenues [Member] · Cigna Healthcare | 1,823 | 1,765 | +3.3% |
| Service, Fees And Other Revenues [Member] · Corporate and Eliminations | -1,584 | -808 | -96.0% |
| Service, Fees And Other Revenues [Member] · Evernorth Health Services | 4,267 | 2,956 | +44.4% |
| Premiums Earned Net (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Employer insured · Cigna Healthcare | 4,775 | 4,451 | +7.3% |
| Individual and Family Plans · Cigna Healthcare | 783 | 935 | -16.3% |
| Medicare Advantage · Cigna Healthcare | 0 | 2,075 | -100.0% |
| Other · Cigna Healthcare | 544 | 1,257 | -56.7% |
| Stop loss · Cigna Healthcare | 1,944 | 1,722 | +12.9% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 61 | 95 | -35.8% |
| Cigna Healthcare · International Health | 1,075 | 937 | +14.7% |
| Cigna Healthcare · Operating Segments | 9,121 | 11,377 | -19.8% |
| Cigna Healthcare · U.S. Healthcare | 8,046 | 10,440 | -22.9% |
Show — breakouts |
|||
| Premiums Earned Net | 9,288 | 11,503 | -19.3% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 106 | 31 | +241.9% |
| Net Investment Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 76 | 78 | -2.6% |
| Cigna Healthcare · Operating Segments | 205 | 155 | +32.3% |
| Evernorth Health Services · Operating Segments | 51 | 39 | +30.8% |
Show — breakouts |
|||
| Net Investment Income | 339 | 277 | +22.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 7 | 5 | +40.0% |
| Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 153 | 201 | -23.9% |
| Cigna Healthcare · Operating Segments | 11,149 | 13,297 | -16.2% |
| Evernorth Health Services · Operating Segments | 63,056 | 53,744 | +17.3% |
Show — breakouts |
|||
| Revenue | 72,472 | 65,649 | +10.4% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | -1,886 | -1,593 | -18.4% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Evernorth Health Services · Operating Segments | 59,700 | 50,510 | +18.2% |
Show — breakouts |
|||
| Cost of Revenue | 57,795 | 49,021 | +17.9% |
| Policyholder Benefits And Claims Incurred Net (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 8,028 | 10,001 | -19.7% |
Show — breakouts |
|||
| Policyholder Benefits And Claims Incurred Net | 8,260 | 10,166 | -18.7% |
| Selling, General & Administrative (Q) | — | — | — |
Show — breakouts |
|||
| Selling, General & Administrative | 3,609 | 3,865 | -6.6% |
| Amortization Of Intangible Assets (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 5 | 9 | -44.4% |
| Evernorth Health Services · Operating Segments | 458 | 415 | +10.4% |
Show — breakouts |
|||
| Amortization Of Intangible Assets | 463 | 424 | +9.2% |
| Benefits Losses And Expenses (Q) | — | — | — |
Show — breakouts |
|||
| Benefits Losses And Expenses | 70,127 | 63,476 | +10.5% |
| Operating Income (Q) | — | — | — |
Show — breakouts |
|||
| Operating Income | 2,345 | 2,173 | +7.9% |
| Other Non-Operating Income (Expense) (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 3 | 0 | — |
| Evernorth Health Services · Operating Segments | 0 | 0 | — |
Show — breakouts |
|||
| Other Non-Operating Income (Expense) | -362 | -362 | 0.0% |
| Gain Loss On Sale Of Business (Q) | — | — | — |
Show — breakouts |
|||
| Gain Loss On Sale Of Business | -66 | 130 | -150.8% |
| Net Investment Gain Loss (Q) | — | — | — |
Show — breakouts |
|||
| Net Investment Gain Loss | -100 | 68 | -247.1% |
| Income Before Taxes (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | -6 | -3 | -100.0% |
| Cigna Healthcare · Operating Segments | 580 | 94 | +517.0% |
| Evernorth Health Services · Operating Segments | 1,725 | 2,435 | -29.2% |
Show — breakouts |
|||
| Income Before Taxes | 1,817 | 2,009 | -9.6% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -482 | -517 | +6.8% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 543 | 473 | +14.8% |
| Net Income (Q) | — | — | — |
Show — breakouts |
|||
| Net Income | 1,274 | 1,536 | -17.1% |
| Net Income Loss Attributable To Noncontrolling Interest (Q) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | 40 | 112 | -64.3% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 4.68 | 5.12 | -8.6% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 4.66 | 5.07 | -8.1% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 1,227 | 1,246 | -1.5% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | -964 | -1,824 | +47.1% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare | 8,030 | 9,999 | -19.7% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 7,676 | 7,550 | +1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 118 | 164 | -28.0% |
| Short-Term Investments (Q) | — | — | — |
Show — breakouts |
|||
| Short-Term Investments | 1,056 | 665 | +58.8% |
Show Investment Type breakouts |
|||
| Debt Securities | 691 | — | — |
| Equity Securities | 22 | — | — |
| Mortgages | 86 | — | — |
| Short Term Investments | 257 | — | — |
| Receivables Net Current (Q) | — | — | — |
Show — breakouts |
|||
| Receivables Net Current | 28,768 | 24,227 | +18.7% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 7,338 | 6,692 | +9.7% |
| Other Assets Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Assets Current | 2,976 | 2,732 | +8.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 29 | 103 | -71.8% |
| Parent Company · Evernorth Health, Inc. | 8.5 | 8.5 | 0.0% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 47,814 | 48,870 | -2.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 147 | 267 | -44.9% |
| Reinsurance Recoverables Non Current (Q) | — | — | — |
Show — breakouts |
|||
| Reinsurance Recoverables Non Current | 4,103 | 4,378 | -6.3% |
| Non-Current Assets | |||
| Long Term Investments (Q) | — | — | — |
Show — breakouts |
|||
| Long Term Investments | 18,471 | 15,128 | +22.1% |
Show Investment Type breakouts |
|||
| Debt Securities | 7,671 | — | — |
| Equity Securities | 3,534 | — | — |
| Mortgages | 1,147 | — | — |
| Other Long Term Investments | 5,037 | — | — |
| Policy Loans | 1,082 | — | — |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare | 8,942 | 8,936 | +0.1% |
| Evernorth Health Services | 35,982 | 35,434 | +1.5% |
Show — breakouts |
|||
| Goodwill | 44,924 | 44,370 | +1.2% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 2,885 | 2,786 | +3.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Nonrelated Party | 48 | 71 | -32.4% |
| Parent Company · Subsidiaries | 14,146 | 10,546 | +34.1% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 157,919 | 155,881 | +1.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 75,723 | 73,771 | +2.6% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 39,547 | 34,395 | +15.0% |
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 3,651 | — | — |
Show Property Plant And Equipment By Type breakouts |
|||
| Other property and equipment | 877 | — | — |
| Software And Software Development Costs | 2,774 | — | — |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 19,969 | — | — |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization (Q) | — | — | — |
Show — breakouts |
|||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3,651 | 3,654 | -0.1% |
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 28,560 | 29,417 | -2.9% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Other Intangible Assets | 191 | — | — |
| Separate Account Asset At Carrying Value (Q) | — | — | — |
Show — breakouts |
|||
| Separate Account Asset At Carrying Value | 7,511 | 7,278 | +3.2% |
| Current Liabilities | |||
| Insurance And Contractholder Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Insurance And Contractholder Liabilities Current | 5,710 | 5,388 | +6.0% |
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 10,659 | 9,294 | +14.7% |
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 592 | 3,035 | -80.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 550 | 2,848 | -80.7% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 56,342 | 57,979 | -2.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,533 | 4,376 | -42.1% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 1.250% Notes due March 2026 | 549 | — | — |
| Non-Current Liabilities | |||
| Insurance And Contractholder Liabilities Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Insurance And Contractholder Liabilities Noncurrent | 9,938 | 10,254 | -3.1% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 7,145 | 6,975 | +2.4% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 4,238 | 3,215 | +31.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Nonrelated Party | 75 | 33 | +127.3% |
| Parent Company · Subsidiaries | 1,134 | 195 | +481.5% |
| Total Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities | 116,045 | 114,638 | +1.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 34,010 | 32,738 | +3.9% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 40,009 | 33,892 | +18.0% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2.375% Notes due March 2031 | 1,420 | 1,384 | +2.6% |
| 2.400% Notes due March 2030 | 1,406 | 1,386 | +1.4% |
| 3.050% Notes due October 2027 | 599 | 598 | +0.2% |
| 3.200% Notes due March 2040 | 748 | 744 | +0.5% |
| 3.400% Notes due March 2027 | 1,481 | 1,466 | +1.0% |
| 3.400% Notes due March 2050 | 1,172 | 1,237 | -5.3% |
| 3.400% Notes due March 2051 | 1,410 | 1,479 | -4.7% |
| 3.875% Notes due October 2047 | 990 | 990 | 0.0% |
| 4.375% Notes due October 2028 | 3,792 | 3,790 | +0.1% |
| 4.500% Notes due September 2030 | 993 | — | — |
| 4.800% Notes due August 2038 | 2,194 | 2,193 | 0.0% |
| 4.800% Notes due July 2046 | 1,469 | 1,469 | 0.0% |
| 4.875% Notes due September 2032 | 1,243 | — | — |
| 4.900% Notes due December 2048 | 2,972 | 2,971 | 0.0% |
| 5.000% Notes due May 2029 | 996 | 995 | +0.1% |
| 5.125% Notes due May 2031 | 750 | 745 | +0.7% |
| 5.250% Notes due February 2034 | 1,250 | 1,226 | +2.0% |
| 5.250% Notes due January 2036 | 1,488 | — | — |
| 5.375% Notes due February 2042 | 315 | 315 | 0.0% |
| 5.400% Notes due March 2033 | 796 | 795 | +0.1% |
| 5.600% Notes due February 2054 | 1,486 | 1,482 | +0.3% |
| 5.875% Notes due March 2041 | 119 | 119 | 0.0% |
| 6.000% Notes due January 2056 | 735 | — | — |
| 6.125% Notes due November 2041 | 484 | 485 | -0.2% |
| 6.150% Notes due November 2036 | 190 | 190 | 0.0% |
| 7.875% Debentures due May 2027 | 260 | 259 | +0.4% |
| Step Down Notes due January 2033 | 45 | 45 | 0.0% |
| Other Liabilities | |||
| Pharmacy And Service Costs Payable (Q) | — | — | — |
Show — breakouts |
|||
| Pharmacy And Service Costs Payable | 30,333 | 28,465 | +6.6% |
| Accrued Expenses And Other Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Expenses And Other Liabilities | 9,048 | 9,387 | -3.6% |
| Long Term Debt And Capital Lease Obligations (Q) | — | — | — |
Show — breakouts |
|||
| Long Term Debt And Capital Lease Obligations | 30,871 | 28,937 | +6.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 30,268 | 28,134 | +7.6% |
| Separate Accounts Liability (Q) | — | — | — |
Show — breakouts |
|||
| Separate Accounts Liability | 7,511 | 7,278 | +3.2% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 4 | 4 | 0.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4 | 4 | 0.0% |
| Additional Paid In Capital Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid In Capital Common Stock | 31,790 | 31,288 | +1.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 31,790 | 31,288 | +1.6% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -2,806 | -2,341 | -19.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,806 | -2,341 | -19.9% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Joint venture in China | -1,672 | -979 | -70.8% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 47,865 | 43,519 | +10.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 47,865 | 43,519 | +10.0% |
| Treasury Stock Value (Q) | — | — | — |
Show — breakouts |
|||
| Treasury Stock Value | -35,140 | -31,437 | -11.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -35,140 | -31,437 | -11.8% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 41,713 | 41,033 | +1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 41,713 | 41,033 | +1.7% |
| Minority Interest (Q) | — | — | — |
Show — breakouts |
|||
| Minority Interest | 161 | 210 | -23.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -944 | -937 | -0.7% |
| Accumulated Other Comprehensive Income | -2,806 | -2,341 | -19.9% |
| Accumulated Translation Adjustment | -127 | -198 | +35.9% |
| Additional Paid In Capital | 31,790 | 31,288 | +1.6% |
| Common Stock | 4 | 4 | 0.0% |
| Net long-duration insurance and contractholder liabilities measurement adjustments | -2,329 | -2,038 | -14.3% |
| Noncontrolling Interest | 161 | 210 | -23.3% |
| Parent | 41,713 | 41,033 | +1.7% |
| Retained Earnings | 47,865 | 43,519 | +10.0% |
| Securities and derivatives | 594 | 832 | -28.6% |
| Treasury Stock Common | -35,140 | -31,437 | -11.8% |
Show — breakouts |
|||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 41,874 | 41,243 | +1.5% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 157,919 | 155,881 | +1.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 75,723 | 73,771 | +2.6% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 3 | 2 | +50.0% |
| Cigna Healthcare · Operating Segments | 87 | 83 | +4.8% |
| Evernorth Health Services · Operating Segments | 628 | 555 | +13.2% |
Show — breakouts |
|||
| Depreciation & Amortization | 722 | 646 | +11.8% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 4 | 6 | -33.3% |
| Increase Decrease In Deferred Income Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Deferred Income Taxes | 500 | 256 | +95.3% |
| Increase Decrease In Accounts And Other Receivables (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accounts And Other Receivables | 2,281 | 3,231 | -29.4% |
| Change in Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | -1,706 | -1,609 | -6.0% |
| Increase Decrease In Reinsurance Recoverable (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Reinsurance Recoverable | -360 | -127 | -183.5% |
| Increase Decrease In Insurance Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Insurance Liabilities | -415 | -377 | -10.1% |
| Increase Decrease In Pharmacy And Service Costs Payable (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Pharmacy And Service Costs Payable | 31 | -222 | +114.0% |
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities | 3,654 | 1,957 | +86.7% |
| Increase Decrease In Other Operating Capital Net (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Other Operating Capital Net | 2 | 119 | -98.3% |
| Net Cash from Operations (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 6,149 | 5,212 | +18.0% |
| Investing Activities | |||
| Proceeds From Sale Of Debt And Equity Securities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale Of Debt And Equity Securities | 264 | 287 | -8.0% |
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities | 241 | 254 | -5.1% |
| Proceeds From Collection Of Loans Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Collection Of Loans Receivable | 25 | 109 | -77.1% |
| Proceeds From Sale And Maturity Of Other Investments (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale And Maturity Of Other Investments | 228 | 185 | +23.2% |
| Payments To Acquire Debt And Equity Securities (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Debt And Equity Securities | -517 | -443 | -16.7% |
| Payments To Acquire Mortgage Notes Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Mortgage Notes Receivable | 0 | 0 | — |
| Payments To Acquire Other Investments (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Other Investments | -350 | -281 | -24.6% |
| Payments For Proceeds From Property Plant And Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Payments For Proceeds From Property Plant And Equipment | -322 | -337 | +4.5% |
| Payments To Acquire Businesses Net Of Cash Acquired (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Businesses Net Of Cash Acquired | 0 | 1 | -100.0% |
| Payments To Acquire Equity Method Investments (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Equity Method Investments | -617 | -564 | -9.4% |
| Other Investing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | -10 | 77 | -113.0% |
| Net Cash from Investing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -420 | -191 | -119.9% |
| Financing Activities | |||
| Additions To Contract Holders Funds (Q) | — | — | — |
Show — breakouts |
|||
| Additions To Contract Holders Funds | 39 | 46 | -15.2% |
| Withdrawal From Contract Holders Funds (Q) | — | — | — |
Show — breakouts |
|||
| Withdrawal From Contract Holders Funds | -52 | -48 | -8.3% |
| Proceeds From Repayments Of Other Short Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Repayments Of Other Short Term Debt | -12 | -768 | +98.4% |
| Repayments Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | -2,554 | 0 | — |
| Proceeds From Issuance Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Long Term Debt | -3 | 0 | — |
| Share Repurchases (Q) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | -1,001 | -2,022 | +50.5% |
| Proceeds From Issuance Of Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Common Stock | 25 | 22 | +13.6% |
| Payments Of Dividends Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends Common Stock | -396 | -384 | -3.1% |
| Proceeds From Payments For Other Financing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Payments For Other Financing Activities | -112 | -94 | -19.1% |
| Net Cash from Financing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -4,066 | -3,248 | -25.2% |
| Supplemental | |||
| Interest Paid (Q) | — | — | — |
Show — breakouts |
|||
| Interest Paid | 307 | 305 | +0.7% |
| Income Taxes Paid (Q) | — | — | — |
Show — breakouts |
|||
| Income Taxes Paid | 43 | 59 | -27.1% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (Q) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2 | -26 | +107.7% |
| Net Change in Cash (Q) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | 1,665 | 1,747 | -4.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 7,736 | 8,931 | -13.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7,736 | 7,592 | +1.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 139 | 190 | -26.8% |
Values in millions USD. Source: SEC EDGAR 10-K filing.